NCT07278388 · Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
What this study is about
This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.
View original scientific description
This proposal aims to understand the neurobiological mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.
Interventions
BEHAVIORAL
Physical Fatigue
Participants will perform a physically demanding task (grip force exertion task) repeatedly to induce physical fatigue.
Primary outcome measures
Comparison between PASC and HC - difference in mean Assessment Error
Time frame: Baseline, during experimental protocol.
The difference between the level of effort rated by participants, and their average grip force exerted on a grip force dynamometer. Compared between PASC and HC.
Comparing between PASC and HC - difference in BBB permeability
Time frame: Baseline, during MRI acquisition.
Collected from and MRI sequence designed to measure BBB permeability.
Comparing between PASC and HC - Regions of the brain that are sensitive to Assessment error as a function of disease state
Time frame: Baseline, during experimental protocol.
We will examine an fMRI contrast, at the time of effort assessment, between HC and PASC groups. This contrast will examine percent signal change in brain activity.
The modulatory effect of BBB permeability on the relationship between Neural Activity and Effort Assessment
Time frame: Baseline, during experimental protocol and MRI aquisition.
We will create a structural equation model that includes BBB permeability, fMRI activity, effort assessment behavior, and disease state (PASC/HC).
Comparing between PASC and HC - Difference in momentary subjective fatigue ratings
Time frame: Baseline and during fatiguing exertions in the experimental protocol.
Measures of subjective fatigue will be collected on self report scale that ranges from 'not fatigued at all' to 'very fatigued'.
Comparing between PASC and HC - Difference in Mean Acceptance Rate of Risky Effort Options between rested/baseline and fatigue choices
Time frame: Baseline and during fatiguing exertions in the experimental protocol.
Proportion of decisions in which inviduals choice to accept a risky effort opitions over a sure effort option.
Comparing between PASC and HC - Regions of the brain encoding a difference in effort cost between rested/baseline and fatigue choices
Time frame: Baseline and during fatiguing exertions in the experimental protocol.
We will examine a contrast between chosen effort value pre versus post fatigue, between the HC and PASC groups. This contrast will examine percent signal change in brain activity.
The modulatory effect of BBB permeability on the relationship between Neural Activity and change effort-based decision-making
Time frame: Baseline, fatigueing exertion, and during experimental protocol and MRI aquisition
We will create a structural equation model that includes BBB permeability, fMRI activity, change in effort-based decision-making, and disease state (PASC/HC).
Comparing between PASC and HC - Difference in mean assessment error as a function of time
Time frame: Data collections at months 0, 3, 6, 12
The difference between the level of effort rated by participants, and their average grip force exerted on a grip force dynamometer. Compared between PASC and HC.
Comparing between PASC and HC - Difference in momentary subjective fatigue ratings as a function of time
Time frame: Data collections at months 0, 3, 6, 12
Measures of subjective fatigue will be collected on self report scale that ranges from 'not fatigued at all' to 'very fatigued'.
Comparing between PASC and HC - difference in BBB permeability as a function of time
Time frame: Data collections at months 0, 3, 6, 12
Collected from and MRI sequence designed to measure BBB permeability.
Comparing between PASC and HC - Regions of the brain that are sensitive to Assessment error as a function of disease state and time
Time frame: Data collections at months 0, 3, 6, 12
We will examine a contrast, at the time of effort assessment, between HC and PASC groups, and use time as a covariate. This contrast will examine percent signal change in brain activity.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Age 18 to 75 years old.
- Have received a clinical diagnosis of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID syndrome using the criteria specified by Thaweethai, et al., 2023 (JAMA). This symptom checklist provides a score based on the number and severity of symptoms. An individual with a score \>12 is classified as having PASC.
- Currently experiencing Fatigue/Brain Fog as assessed with the Post-COVID symptom checklist and the PedsQL questionnaire.
Exclusion criteria
- Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report).
- Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report).
- Congestive heart failure.
- Peripheral artery disease with claudication.
- Pulmonary or renal failure.
- Unstable angina.
- Uncontrolled hypertension (more than 190/110 mmHg).
- Severe aphasia.
- Orthopedic or pain conditions.
- Have had exposure to metal or metal implants, due to the hazardous effects of the magnetic field.
- If on immunomodulatory therapy, they must have been on that therapy for at least 6 months before the start of the study. Healthy age- and sex-matched controls for PASC - Exclusion criteria: Participants with a history of any of the following will be excluded from the study:
- Hospitalization due to SARS-CoV-2 infection.
- Neurological disorders including, but not limited to, stroke, head injury, epilepsy, seizures, brain tumors, brain surgery, Parkinson's Disease, or any other neuromuscular disease (self-report).
- Diagnosed history of severe psychiatric diseases such as depression and schizophrenia (self-report).
- Congestive heart failure.
- Peripheral artery disease with claudication.
Where
- Baltimore, Maryland
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Dec 12, 2025 · Source of record for eligibility and locations